Provided by Tiger Fintech (Singapore) Pte. Ltd.

AEON Biopharma

0.7317
-0.0461-5.93%
Post-market: 0.73170.00000.00%19:56 EDT
Volume:55.81K
Turnover:41.31K
Market Cap:8.52M
PE:-1.84
High:0.7778
Open:0.7691
Low:0.7272
Close:0.7778
52wk High:115.57
52wk Low:0.3750
Shares:11.64M
Float Shares:8.20M
Volume Ratio:0.62
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3985
EPS(LYR):77.74
ROE:--
ROA:-129.01%
PB:-0.54
PE(LYR):0.01

Loading ...

Company Profile

Company Name:
AEON Biopharma
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
5
Office Location:
5 Park Plaza,Suite 1750,Irvine,California,United States
Zip Code:
92614
Fax:
- -
Introduction:
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.